Clinical Trials in Massachusetts

Showing 5861-5880 of 13,570 trials

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

NCT00930943

The purpose of the study is to determine whether extended-release oxymorphone hydrochloride taken orally with a high-fat meal, generating an approximately 50% higher Cmax, impacts cognitive functioning, using Cambridge Neuropsychological Test Automated Battery (CANTAB) tests, to a greater extent than when taking under conditions of fasting.

Chronic Pain

MedVadis Research Corporation30 participantsStarted May 2009

Wellesley Hills, Massachusetts, United States

TERMINATEDPhase 318 miles

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

NCT04745351

The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation (IMV) through Day 29 in participants with severely reduced kidney function who are hospitalized for coronavirus disease 2019 (COVID-19).

COVID-19

Gilead Sciences249 participantsStarted Mar 2021

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +60 more locations

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

Find Trials by Condition in Massachusetts

Subject Evaluation of a 1064nm Diode Laser/RF

HBV-HIV Coinfection Research Network

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

The T1D Exchange Registry

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Eye Movement Rehabilitation in Low Vision Patients

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer